Stockscreener 앱 받기
213.07
9.28%
16.07
전일 마감가:
$197.00
열려 있는:
$199
하루 거래량:
10.12M
Relative Volume:
0.61
시가총액:
$85.25B
수익:
$2.23B
순이익/손실:
$-3.19B
주가수익비율:
-26.16
EPS:
-8.1462
순현금흐름:
$-1.60B
1주 성능:
+13.30%
1개월 성능:
+58.75%
6개월 성능:
+319.81%
1년 성능:
+681.98%
1일 변동 폭
$197.17
$216.95
1주일 범위
$182.50
$216.95
52주 변동 폭
$22.28
$216.95
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
Compare MRNA vs VRTX, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
213.53 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
VRTX
Vertex Pharmaceuticals Inc
|
511.30 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
745.66 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.13 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.79 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 재개 | Barclays | Equal Weight |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-12 | 개시 | Jefferies | Hold |
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
Moderna stock after-hours at EUR 170.09: plus 0.70 percent versus the prior close - AD HOC NEWS
Moderna Stock Is Trending: What's Going On? - Benzinga
Top Healthcare Stocks To Watch TodayOctober 1st - MarketBeat
Moderna loses US government license defense in Northwestern patent case - reuters.com
Why Citi Is Sounding the Alarm on Moderna Stock - Barchart.com
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water - Yahoo Finance
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water - 247wallst.com
Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test - Simply Wall Street
The Escalator: Moderna, Hatteras Venture Partners, PhRMA and more - Medical Marketing and Media
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet - FinancialContent
Moderna adds COO role. Moderna stock falls 1.40 percent - AD HOC NEWS
Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market - Barron's
Moderna, Inc. Announces Management Changes - marketscreener.com
Why Moderna (MRNA) Shares Are Falling Today - Yahoo Finance
This Analyst Just Downgraded Moderna Stock. Here's Why. - Yahoo Finance
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline - Barron's
Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year - Investopedia
Moderna Shares Reverse Weakness, Rise Over 3% After Key Trading Signal - Benzinga
Citi delivers major verdict after Moderna’s remarkable 703% run - thestreet.com
Prediction: Moderna Stock Will Soar 100% by 2030 - Yahoo Finance
Prediction: Moderna Stock Will Soar 100% by 2030 - The Motley Fool
What's Going On With Moderna Stock on Wednesday? - Benzinga
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? - Zacks Investment Research
Moderna Tumbles as Citi Advises Selling Following 600% Rally - Bloomberg.com
Moderna (MRNA) Options Traders Turn Moderately Bearish Amid Pric - GuruFocus
Moderna (NASDAQ:MRNA) Shares Gap DownHere's Why - MarketBeat
Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter - Barron's
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains - MarketWatch
Moderna (MRNA) Shares Drop 6.88% Premarket After Citi Downgrade Citing Valuation Concerns - GuruFocus
Moderna Inc Stock (MRNA) Opened Down by 6.27% on Sep 30: Key Drivers Unveiled - TradingKey
Three biotech updates, including accusations of theft and and a new lobbying leader - statnews.com
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat - Yahoo Finance
Target upgraded, Moderna downgraded: Wall Street's top analyst calls - Yahoo Finance
MRNA Stock Downgraded As Valuation Fears Eclipse Cancer Win - StocksToTrade
MRNA Stock Downgraded As Valuation Fears Clash With Trial Success - timothysykes.com
Moderna (MRNA) Shares Fall Premarket After Citi Downgrades to Se - GuruFocus
MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum - Yahoo Finance
Premarket movers: Micron; Boeing rises, Moderna slides - Yahoo Finance
Moderna Names Juan Andres as COO - marketscreener.com
Moderna stock slips as Citi cuts to Sell (MRNA:NASDAQ) - Seeking Alpha
Moderna: Citi says oncology optimism is priced in, cuts rating to sell - Yahoo! Finance Canada
Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic” - TipRanks
Moderna names Juan Andres chief operating officer - TradingView
Moderna names Juan Andres as chief operating officer - Investing.com
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology - ACCESS Newswire
Moderna, Inc. (MRNA) Adds COO; Andres Returns, Collins Retires - TradingView
Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60 - marketscreener.com
Moderna Sets Another Fresh 52-Week High: What's Happening? - Benzinga
Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines - Bloomberg Law News
Moderna And Merck: The Intismeran Readout That Was Worth $86 Billion (NASDAQ:MRNA) - Seeking Alpha
Precision Trading with Moderna Inc. (MRNA) Risk Zones - Stock Traders Daily
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
모더나 주식 (MRNA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hoge Stephen | President |
Sep 15 '26 |
Option Exercise |
12.21 |
76,452 |
933,479 |
1,602,310 |
| Hoge Stephen | President |
Sep 15 '26 |
Sale |
146.07 |
40,281 |
5,883,846 |
1,562,029 |
| Hoge Stephen | President |
Sep 14 '26 |
Sale |
144.13 |
40,294 |
5,807,574 |
1,525,858 |
0.98%
0.75%
자본화:
|
볼륨(24시간):